Purple Biotech - Stock Price History | PPBT

Historical daily share price chart and data for Purple Biotech since 2021 adjusted for splits. The latest closing stock price for Purple Biotech as of September 24, 2021 is 4.79.
  • The all-time high Purple Biotech stock closing price was 66.80 on May 16, 2016.
  • The Purple Biotech 52-week high stock price is 7.25, which is 51.4% above the current share price.
  • The Purple Biotech 52-week low stock price is 3.60, which is 24.8% below the current share price.
  • The average Purple Biotech stock price for the last 52 weeks is 4.57.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Purple Biotech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 5.3540 7.8000 12.6000 2.3000 3.8100 -51.13%
2019 9.3833 7.5000 28.0000 6.8000 7.7960 18.12%
2018 20.6127 23.6000 30.3000 6.2210 6.6000 -71.05%
2017 20.7710 31.7000 33.5000 12.9000 22.8000 -26.69%
2016 36.7399 30.8850 66.8000 23.3000 31.1000 -1.27%
2015 31.3643 31.9000 44.7000 24.3000 31.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.127B $0.001B
Purple Biotech Ltd. is a clinical-stage company focusing on therapies to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline includes NT219 and CM24. Purple Biotech Ltd., formerly known as Kitov Pharma Ltd., is based in TEL AVIV, Israel.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71